Dendritic Cell/AML Fusion Cell Vaccine Following Allogeneic Transplantation in AML Patients
Clinical trial NCT03679650 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03679650
- Sponsor
- Beth Israel Deaconess Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-11
- Primary completion
- 2026-03-31
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.